MAPT and Alzheimer disease: Lastly, Liguori et al. (2017) found a significant increase in CSF orexin in AD patients and that hypothalamic glucose consumption correlated negatively with the CSF T-tau/Aβ42 ratio suggesting a causative link between mitochondrial function, AD pathology, and orexin.